Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer

about

NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest.

P2860

Q54978331-A6EBDAEA-B2F3-45DA-909D-A7769FD5EDC2

P2860

Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer

Item

http://www.wikidata.org/entity/Q35951787

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer

@ast

Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer

@en

type

Item

label

Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer

@ast

Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer

@en

prefLabel

Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer

@ast

Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer

@en

P1476

Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer

@en

P2093

Achim Rody

http://www.w3.org/2001/XMLSchema#string

Lajos Pusztai

http://www.w3.org/2001/XMLSchema#string

Marcus Schmidt

http://www.w3.org/2001/XMLSchema#string

Sven Becker

http://www.w3.org/2001/XMLSchema#string

Uwe Holtrich

http://www.w3.org/2001/XMLSchema#string

Volkmar Müller

http://www.w3.org/2001/XMLSchema#string

P2860

Bioconductor: open software development for computational biology and bioinformatics

affy--analysis of Affymetrix GeneChip data at the probe level

Data-driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer.

Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.

A clinically relevant gene signature in triple negative and basal-like breast cancer

Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation.

P304

354-356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.GDATA.2014.09.014

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Thomas Karn

P577

2014-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275533391

http://www.w3.org/2001/XMLSchema#string

P698

26484129

http://www.w3.org/2001/XMLSchema#string

P921

bias

P932

4535974

http://www.w3.org/2001/XMLSchema#string

Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer

about

P2860

P2860

Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P921

P932